Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Professor Ironside reported to the HCDO the first positive result detecting the abnormal prion protein found in vCJD in a spleen sample from a patient included in the DH-funded prevalence study of vCJD infection in haemophilia.

  • Read more about Professor Ironside reported to the HCDO the first positive result detecting the abnormal prion protein found in vCJD in a spleen sample from a patient included in the DH-funded prevalence study of vCJD infection in haemophilia.

In an email chain discussing a "Telegraph" article about a post-mortem which was carried out on a man with haemophilia which found the vCJD prion in his spleen, it was held that an update should be urgently sent to people with bleeding disorders saying that "

  • Read more about In an email chain discussing a "Telegraph" article about a post-mortem which was carried out on a man with haemophilia which found the vCJD prion in his spleen, it was held that an update should be urgently sent to people with bleeding disorders saying that "

In the first Advisory Committee on Dangerous Pathogens Transmissible Spongiform Encephalopathy Risk Assessment Sub-Group meeting, it advised the Department of Health that the policy adopted thus far had largely been driven by the "'worst case' scenarios".

  • Read more about In the first Advisory Committee on Dangerous Pathogens Transmissible Spongiform Encephalopathy Risk Assessment Sub-Group meeting, it advised the Department of Health that the policy adopted thus far had largely been driven by the "'worst case' scenarios".

In her written statement, Dr Angela Robinson described a shift in approach which she attributed to Dr Kenneth Calman: the concept of the 'precautionary principle' was introduced and at that stage they were doing enormous things at great cost which had not been done before.

  • Read more about In her written statement, Dr Angela Robinson described a shift in approach which she attributed to Dr Kenneth Calman: the concept of the 'precautionary principle' was introduced and at that stage they were doing enormous things at great cost which had not been done before.

In her written statement, Dr Hewitt stated that the strongly held views of those who supported notification of those possibly affected and those against might have led to erring on the side of not acting soon enough.

  • Read more about In her written statement, Dr Hewitt stated that the strongly held views of those who supported notification of those possibly affected and those against might have led to erring on the side of not acting soon enough.

In her written statement, Dr Miflin expressed that as a result of the difficulty in testing blood for vCJD, and as a result of the experience of HIV and HCV in the preceding decades, a precautionary approach was taken regarding the emergence of vCJD in the mid 1990s.

  • Read more about In her written statement, Dr Miflin expressed that as a result of the difficulty in testing blood for vCJD, and as a result of the experience of HIV and HCV in the preceding decades, a precautionary approach was taken regarding the emergence of vCJD in the mid 1990s.

During 2005, following the diagnosis of vCJD in two more former donors, a further ten living recipients of implicated blood components had been notified and asked to take special public health precautions.

  • Read more about During 2005, following the diagnosis of vCJD in two more former donors, a further ten living recipients of implicated blood components had been notified and asked to take special public health precautions.

This Department of Health paper recalculated the risk of blood-borne transmission of vCJD.

  • Read more about This Department of Health paper recalculated the risk of blood-borne transmission of vCJD.

Some sections of the framework document on management of possible exposure to CJD through medical procedures included establishing a confidential database without consent, estimates of the infectivity of blood components and plasma derivatives, and advice on the investigation and management of incidents involving blood, were "greyed out" as they had not yet been finalised.

  • Read more about Some sections of the framework document on management of possible exposure to CJD through medical procedures included establishing a confidential database without consent, estimates of the infectivity of blood components and plasma derivatives, and advice on the investigation and management of incidents involving blood, were "greyed out" as they had not yet been finalised.

In the interim report on incident involving blood components and vCJD and the patient notification exercise, it was stated that the Department of Health asked the Health Protection Agency to take the lead in notifying people.

  • Read more about In the interim report on incident involving blood components and vCJD and the patient notification exercise, it was stated that the Department of Health asked the Health Protection Agency to take the lead in notifying people.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 580
  • Page 581
  • Page 582
  • Page 583
  • Current page 584
  • Page 585
  • Page 586
  • Page 587
  • Page 588
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.